About
Paul J. Skipp is a Professor of Proteomics at the ºÚÁÏÉç and Director of the Centre for Proteomic Research. His research group address a wide range of complex biological problems using proteomics in combination with other omic technologies and data analysis approaches, resulting in 100+ publications, collaborating with academia and industry. A large focus of his research is in the area of clinical proteomics, across the areas of respiratory, allergy, infection and cancer, applying and developing Precision Medicine based approaches to generate a better understanding for the diagnosis, stratification and treatment of disease. He is also founder of two spinout companies, , an artificial intelligence company created to advance Precision Medicine through rapid discovery of pathway biomarkers for precise diagnosis and prognosis informing therapeutic treatment and; - a healthcare company developing a multi-cancer early detection screenng test.
An updated list of publications can be found here:
Research
Research groups
Research projects
Active projects
Completed projects
Publications
Pagination
- 1
- 2
- 3
- 4
- 5
- …
-
Next page
Next
Biography
Paul J. Skipp is a Professor of Proteomics at the ºÚÁÏÉç and Director of the Centre for Proteomic Research. His research group address a wide range of complex biological problems using proteomics in combination with other omic technologies and data analysis approaches, resulting in 100+ publications, collaborating with academia and industry. A large focus of his research is in the area of clinical proteomics, across the areas of respiratory, allergy, infection and cancer, applying and developing Precision Medicine based approaches to generate a better understanding for the diagnosis, stratification and treatment of disease. He is also founder of two spinout companies, , an artificial intelligence company created to advance Precision Medicine through rapid discovery of pathway biomarkers for precise diagnosis and prognosis informing therapeutic treatment and; - a healthcare company developing a multi-cancer early detection screenng test.
An updated list of publications can be found here: